Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|October 27, 2004
Nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasmaHarald Noedl, Paktiya Teja-Isavadharm, Robert Scott MillerAntimicrobial Agents and Chemotherapy|May 23, 2002
Histidine-rich protein II: a novel approach to malaria drug sensitivity testingHarald Noedl, Walther H Wernsdorfer, Robert Scott Miller, et al.Malaria Journal|August 3, 2012
Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b studyRobert Scott Miller, Qigui Li, Louis R Cantilena, et al.Wiener Klinische Wochenschrift|November 30, 2006
[In vitro antimalarial drug resistance in Southeastern Bangladesh]Bernhard Attlmayr, Kamala Thriemer, Rashidul Haque, et al.Experimental Parasitology|July 15, 2003
Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein IIHarald Noedl, Chansuda Wongsrichanalai, Robert Scott Miller, et al.Malaria Journal|December 16, 2006
Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in ThailandRussell E Coleman, Jetsumon Sattabongkot, Sommai Promstaporm, et al.Antimicrobial Agents and Chemotherapy|November 23, 2006
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcomeHarald Noedl, Srivicha Krudsood, Wattana Leowattana, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in ThailandHarald Noedl, Srivicha Krudsood, Kobsiri Chalermratana, et al.Pageof 1